Celestica Inc. (CLS)
Celestica (CLS) Stock Slides as Market Rises: Facts to Know Before You Trade
The latest trading day saw Celestica (CLS) settling at $266.98, representing a -3.84% change from its previous close.
Is Most-Watched Stock Celestica, Inc. (CLS) Worth Betting on Now?
Celestica (CLS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Is Celestica (CLS) Down 7% Since Last Earnings Report?
Celestica (CLS) reported earnings 30 days ago. What's next for the stock?
Celestica (CLS) is an Incredible Growth Stock: 3 Reasons Why
Celestica (CLS) possesses solid growth attributes, which could help it handily outperform the market.
Celestica: I Was Wrong, Upgrading On Strong Support
Celestica is upgraded to 'Buy' as I now recognize the enduring strength of AI tailwinds and management's execution. CLS achieved a 17th consecutive dual earnings beat, with Q4 EPS up 70% YoY and full-year EPS up 55%. Robust balance sheet, low leverage, and accelerating AI capex from hyperscalers position CLS for further upside and multiple compression.
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
New Strong Buy Stocks for February 18th
SPFI, RIO, CLS, PCB and PINE have been added to the Zacks Rank #1 (Strong Buy) List on February 18th, 2026.
Celestica's Next Move Is Scale
Celestica remains a classic picks-and-shovels winner in AI infrastructure, with a unique engineering-led hardware platform. CLS's growth is driven by its Connectivity & Cloud Solutions segment, supplying hyperscalers and AI builders as data center demand accelerates. The company's engineering-led, IP-based hardware platform solutions differentiate CLS beyond its manufacturing footprint.
Celestica: Why The $1B CAPEX Surge Is A Buy Signal, Not A Red Flag
Celestica has successfully transitioned from a traditional EMS player to a mission-critical partner for AI hyperscalers, achieving a robust 7.7% operating margin. Traditional P/E multiples have become irrelevant in 2026 due to the company's massive $1 billion CAPEX investment cycle, which temporarily masks true earnings power. When valued on an EV/Sales basis (1.90x), CLS trades at a significant discount to the "AI infrastructure basket", implying a total return potential of over 100%.
Can Rising Defense Demand Boost Celestica's Future Growth Prospects?
CLS plays a pivotal role in global defense, delivering rugged, mission-critical electronics and lifecycle support as military spending climbs.
CLS vs. JBL: Which EMS Stock is a Better Buy Right Now?
AI data center expansion is intensifying competition between Celestica and Jabil, as hyperscaler deals, next-gen switches and rising estimates reshape the EMS landscape.
Celestica, Inc. (CLS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.
